Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Endocrinology|April 28, 2007
Permethrin may disrupt testosterone biosynthesis via mitochondrial membrane damage of Leydig cells in adult male mouseShu-Yun Zhang, Yuki Ito, Osamu Yamanoshita, et al.Toxicology Letters|February 11, 2010
Bisphenol A may cause testosterone reduction by adversely affecting both testis and pituitary systems similar to estradiolDaichi Nakamura, Yukie Yanagiba, Zhiwen Duan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4Li Liu, Patrick A Mayes, Stephen Eastman, et al.Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agentsZilun Hu, Xiangjun Jiang, Charles F Albright, et al.Cancer Research|January 22, 2013
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activityCharity Atkins, Qi Liu, Elisabeth Minthorn, et al.Plos One|July 1, 2014
Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitorMelissa Dumble, Ming-Chih Crouthamel, Shu-Yun Zhang, et al.Chemosphere|March 12, 2021
Chrysene, a four-ring polycyclic aromatic hydrocarbon, induces hepatotoxicity in mice by activation of the aryl hydrocarbon receptor (AhR)Li-Ping Tao, Xue Li, Ming-Zhu Zhao, et al.Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.Nature Chemical Biology|January 7, 2014
Allosteric Wip1 phosphatase inhibition through flap-subdomain interactionAidan G Gilmartin, Thomas H Faitg, Mark Richter, et al.Molecular Cancer Therapeutics|May 18, 2005
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityCharles F Albright, Nilsa Graciani, Wei Han, et al.Pageof 5